JP Morgan Chase
AGN

JP Morgan Chase’s Allergan plc AGN Stock Holding History

JP Morgan Chase’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88,000
Closed -$14.8M – 6043
2019
Q3 		$14.8M Sell
88,000
-44,000
-33% -$7.17M ﹤0.01% 1824
2019
Q2 		$21.9M Buy
132,000
+68,000
+106% +$9.42M ﹤0.01% 1507
2019
Q1 		$9.37M Buy
64,000
+23,800
+59% +$3.45M ﹤0.01% 2111
2018
Q4 		$5.37M Sell
40,200
-22,800
-36% -$3.74M ﹤0.01% 2520
2018
Q3 		$12M Sell
63,000
-127,200
-67% -$23.4M ﹤0.01% 2046
2018
Q2 		$31.7M Buy
190,200
+131,700
+225% +$21.1M 0.01% 1255
2018
Q1 		$9.85M Sell
58,500
-4,000
-6% -$671K ﹤0.01% 2043
2017
Q4 		$10.2M Sell
62,500
-61,600
-50% -$11.1M ﹤0.01% 2102
2017
Q3 		$25.3M Buy
124,100
+24,600
+25% +$5.72M 0.01% 1341
2017
Q2 		$24.2M Buy
99,500
+82,500
+485% +$19.4M 0.01% 1329
2017
Q1 		$4.06M Sell
17,000
-174,200
-91% -$40.6M ﹤0.01% 2579
2016
Q4 		$40.2M Buy
191,200
+26,514
+16% +$5.49M 0.01% 1029
2016
Q3 		$37.9M Sell
164,686
-380,985
-70% -$93.1M 0.01% 964
2016
Q2 		$126M Sell
545,671
-249,029
-31% -$57.4M 0.03% 499
2016
Q1 		$213M Buy
794,700
+152,588
+24% +$43.7M 0.05% 351
2015
Q4 		$201M Buy
642,112
+344,612
+116% +$103M 0.05% 387
2015
Q3 		$80.9M Buy
+297,500
New +$91.4M 0.02% 610
2015
Q2 		– Sell
-45,000
Closed -$13.4M – 4270
2015
Q1 		$13.4M Sell
45,000
-76,610
-63% -$21.8M ﹤0.01% 1702
2014
Q4 		$31.3M Buy
+121,610
New +$30.4M 0.01% 1203

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

JP Morgan Chase's AGN Position: Q2 2020 in Review

JP Morgan Chase sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,705,099 shares — an estimated $656M sold.

JP Morgan Chase first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $2.07B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • JP Morgan Chase reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • JP Morgan Chase sold 3,705,099 Allergan plc shares in Q2 2020, an estimated $656M.
  • JP Morgan Chase first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • JP Morgan Chase's Allergan plc position peaked at $2.07B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.